2022 American Transplant Congress

TOPIC: Clinical Science » Organ Inclusive » 67 - Non-PTLD/Malignancies

Association of Native Kidney Disease with De Novo Cancer Development After Kidney Transplant
Y. Caliskan¹, D. Axelrod², R. Li¹, W. Cheungpasitporn³, M. Schnitzler¹, M. McAdams DeMarco⁴, J. Ahn⁴, T. Alhamad⁵, H. Randall¹, S. Bae⁴, D. Segev⁴, K. L. Lentine¹
Characterizing the Landscape of Cancer Risk Following HLA-Incompatible Living Donor Kidney Transplantation
J. D. Motter¹, K. Jackson¹, K. Yu², R. M. Pfeiffer², A. Massie¹, J. Garonzik-Wang³, D. Segev¹, E. A. Engels²
Cutaneous Angiosarcoma in Solid Organ Transplant Recipients – Novel Case & Review of the Literature
S. M. Elzein, R. R. Caplan
De Novo Fibrinogen Alpha Chain Amyloidosis in Kidney Allograft
T. Khaja¹, L. Truong², G. Nassar¹
Donor-Derived Duodenal Adenocarcinoma of a Bladder-Drained Pancreas Allograft
D. Isaacson¹, J. Steggerda¹, Y. Xue¹, G. B. Auffenberg², N. N. Katariya³
Kidney Transplantation in Patients Postradical Prostatectomy
S. Karhadkar, K. Wirshup, J. Kolansky, A. Gregor, J. Dawes, A. DiCarlo
Metastatic BK Virus-Associated Urothelial Carcinoma Originating in Renal Allograft
J. Torrealba¹, H. Jones¹, A. Bhakta², L. Jia¹, D. Wojciechowski²
Mortality in Solid Organ Transplant Recipients with a Pretransplant Cancer Diagnosis
A. Hart¹, R. Pfeiffer², B. Morawski³, C. Lynch⁴, Y. Zeng⁵, K. Pawlish⁶, K. Yu⁷, D. Hurley⁸, E. Engels⁷
Prevalence and Clinical Significance of Pancreatic Cystic Lesions in Immunosuppressed Patients with Solid Organ Transplantation
Y. Yu, H. Jo, Y. Choi, J. Lee, D. Kim